OpenVSafe by OpenVAERS
Search V-safe

TYH-21202-63054

2 vaccinations 2 coded responses 2 check-ins 1 free-text entry 2 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
954 / CA
Registered
2022-06-21
Relationship
Child or adolescent in my care
Guardian
G2Q-28290-04531
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2419387 (opens in a new window) high 9 / 11 — 2 of 12 VAERS symptoms same dose (2) CA matches 2022-02-22 / 2022-05-13 / 2022-08-24
received the same day as the last call
case 960146

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2022-01-28
    Dose 1 — Pfizer-BioNTech
  2. 2022-02-22
    Dose 2 — Pfizer-BioNTech
  3. 2022-06-21
    Registered in v-safe
  4. 2022-08-23
    Survey response — 6 months, dose 2, dependent
    MedDRA: Diarrhoea, Nasal congestion, Nasopharyngitis, Pre-existing disease, SARS-CoV-2 test negative, Sinusitis, Sneezing — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Had allergies that turned into a nose infection and recently Had a cold with stuffy nose, sneezing, and diarrhea (home COVID test was negative)
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-08-23
    Report sent to call center — 6 months, dose 2, dependent
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  6. 2022-08-24
    Call successful
    Completed over the phone
  7. 2023-02-24
    Survey response — 12 months, dose 2, dependent
    MedDRA: Influenza, Pulmonary congestion, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  8. 2023-02-24
    Report sent to call center — 12 months, dose 2, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  9. 2023-02-27
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12022-01-28Pfizer-BioNTech No
22022-02-22Pfizer-BioNTech No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 12 — 6 months, dose 2, dependent

2022-08-23

Symptoms: Had allergies that turned into a nose infection and recently Had a cold with stuffy nose, sneezing, and diarrhea (home COVID test was negative)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDiarrhoea · · ✓
SDInfluenza · · ✓
SDNasal congestion · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SDPulmonary congestion · · ✓
SDRespiratory disorder · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release